Verastem (VSTM) Tops Q4 EPS by 2c

Verastem (NASDAQ: VSTM) reported Q4 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Verastem (VSTM) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Aspire Biopharma to acquire automotive supplier for $30 million
• Independent Bank receives regulatory approval for HCB Financial acquisition